Allergy/Immunology · Kissimmee, FL
NPI
1922071158
Since 2006
Specialty
Allergy/Immunology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
903 W Oak St
Kissimmee, FL, 34741
Phone (407) 846-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$171K
8,308 services
Medicare patients, 2024
187
Average age 71
Drug cost, 2024
$2.8M
2,900 prescriptions
Company payments, 2025
$646
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Imtiaz Ahmed was code 95004 (test - miscellaneous), 2,075 times for 36 patients. In total Imtiaz Ahmed billed 8,308 services in 23 codes, and Medicare paid $171K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-06-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 2,075 | 36 | $2.70 | $5,610 |
| 95165 Treatment - Miscellaneous | Office | 789 | 52 | $10.13 | $7,996 |
| 95117 Treatment - Miscellaneous | Office | 757 | 60 | $7.76 | $5,871 |
| 95115 Treatment - Miscellaneous | Office | 355 | 25 | $6.99 | $2,480 |
| 95024 Test - Miscellaneous | Office | 229 | 14 | $5.81 | $1,330 |
| 96401 Chemotherapy Administration | Office | 182 | 16 | $44.25 | $8,054 |
| 99214 Office E&M - Established | Office | 109 | 68 | $92.35 | $10K |
| 99213 Office E&M - Established | Office | 106 | 84 | $65.47 | $6,940 |
| 99204 Office E&M - New | Office | 36 | 36 | $128.72 | $4,634 |
| 99203 Office E&M - New | Office | 19 | 19 | $77.74 | $1,477 |
By year: 2022 $210K for 10,206 services; 2023 $189K for 9,244 services; 2024 $171K for 8,308 services.
Medicare prescription drug claims, 2024
In 2024, the drug Imtiaz Ahmed prescribed most often to Medicare patients was Montelukast Sodium, with 555 prescriptions and refills. In total Imtiaz Ahmed wrote 2,900 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 555 | 1,118 | 212 | $4,539 |
| Levocetirizine Dihydrochloride Generic | 364 | 679 | 139 | $4,379 |
| Fluticasone Propionate Generic | 227 | 452 | 105 | $2,507 |
| Xolair Omalizumab | 152 | 152 | 21 | $394K |
| Azelastine Hcl Generic | 108 | 190 | 52 | $2,470 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 102 | 138 | 34 | $87K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 101 | 117 | 61 | $2,481 |
| Dupixent Pen Dupilumab | 99 | 99 | 20 | $396K |
| Prednisone Generic | 66 | 66 | 53 | $128 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 65 | 65 | 15 | $41K |
| Triamcinolone Acetonide Generic | 64 | 74 | 45 | $1,225 |
| Fluocinolone Acetonide Generic | 63 | 63 | 38 | $3,434 |
| Epinephrine Generic | 52 | 101 | 44 | $12K |
| Doxepin Hcl Generic | 44 | 44 | 12 | $373 |
| Symbicort Budesonide/Formoterol Fumarate | 40 | 53 | Under 11 | $12K |
Brand drugs: - claims; generic drugs: 2,098 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Imtiaz Ahmed $646 ($646 in general payments such as food, travel and fees) from 15 companies. The largest payer was Novartis Pharmaceuticals Corporation with $152.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 5 | $152 |
| Pfizer Inc. PFE | 3 | $74.54 |
| Grifols USA, LLC | 3 | $74.19 |
| Genentech USA, Inc. ROG.SW | 2 | $57.92 |
| GlaxoSmithKline, LLC. GSK | 2 | $43.05 |
| BioCryst US Sales Co., LLC | 1 | $34.92 |
| Cycle Pharmaceuticals Inc | 1 | $28.77 |
| CSL Behring CSL.AX | 2 | $27.5 |
| Ionis Pharmaceuticals, Inc. IONS | 1 | $25.67 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $24.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.